Home/Smart Money/ARCH Venture Management, LLC
§ 13F · FUND PROFILE

ARCH Venture Management, LLC.

Institutional filer · behavioral pattern: Other. Summary pending.
AUM · (13F)Positions · 9Turnover · · Q4Filed · Feb 17, 2026
CONCENTRATION
Top 10 holdings
NEW BUYS
0
+$651.7T deployed
EXITS
0
No exits
SECTOR SHIFT
No prior quarter data
3YR HIT RATE
Top-5 overlap
§ 01 · TOP HOLDINGS

The book · Q4 2025

FILED FEB 17, 2026
#TickerNameShares$ value% portΔ Q4
1MAZEMAZE THERAPEUTICS INC.4.12M$170.7T26.2%NEW
2BEAMBEAM THERAPEUTICS INC.4.54M$125.9T19.3%NEW
3RAPPRAPPORT THERAPEUTICS INC.3.73M$113.1T17.4%NEW
4LYELLYELL IMMUNOPHARMA INC.2.76M$84.9T13.0%NEW
5VIRVIR BIOTECHNOLOGY INC.12.92M$77.9T12.0%NEW
6ERASERASCA INC.11.06M$41.1T6.3%NEW
7GOSSGOSSAMER BIO INC.8.06M$25.0T3.8%NEW
8TXG10X GENOMICS INC.738K$12.0T1.8%NEW
9QTTBQ32 BIO INC.320K$1.1T0.2%NEW
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE ARCH SIGNAL

AC read

ARCH Venture Management, LLC is classified as a Other fund.

Read the full dossier →
§ 04 · FILING HISTORY

Q-by-Q deltas

1 FILINGS
Q4 2025
Steady book
+0 buys · 0 exits · 0 changed
Q1 2025
Steady book
+0 buys · 0 exits · 0 changed